The Department of Health and Human Services today announced a $31 million agreement with Emergent BioSolutions to develop an anthrax vaccine that could provide protection in fewer doses. “Anthrax remains a national health security threat, and we’re striving to develop an anthrax vaccine that affords immunity sooner and with fewer doses,” said Robin Robinson, director of the Biomedical Advanced Research and Development Authority. “If it works, this vaccine may help achieve better preparedness at a lower cost.”